BPG is committed to discovery and dissemination of knowledge
Articles in Press
10/5/2019 7:02:04 AM | Browse: 285 | Download: 335
Category |
Obstetrics & Gynecology |
Manuscript Type |
Case Report |
Article Title |
Apatinib treatment in a pseudomyxoma peritonei patient after surgical treatment and hyperthermic intraperitoneal chemotherapy: A case report
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Rong Huang, Xiu-Ling Shi, Yun-Fei Wang, Fei Yang, Ting-Tao Wang and Cun-Xu Peng |
Funding Agency and Grant Number |
|
Corresponding Author |
Cun-Xu Peng, N/A, Doctor, Professor, Surgeon, Department of Gynecology, The Affiliated Hospital of Jining Medical University, Jining Medical University, 89 Guhuai Road, Jining 272000, Shandong Province, China. pengcunxu@aliyun.com |
Key Words |
Pseudomyxoma peritonei; Abdominal distention; Anti-angiogenic agent; Apatini; Case report; - |
Core Tip |
The preferred treatment for pseudomyxoma peritonei (PMP) is surgery, but it is easy to relapse after surgery. There is currently no good treatment for patients with postoperative recurrence. In this work,the PMP patient received apatinib for recurrent abdominal distension after surgical treatment and hyperthermic intraperitoneal chemotherapy. After treatment with apatinib, the recurrence time was significantly prolonged. Apatinib, a small-molecule oral inhibitor with anti-angiogenic function, may be an option for recurrent PMP after surgical treatment. |
Citation |
Huang R, Shi XL, Wang YF, Yang F, Wang TT, Peng CX. Apatinib treatment in a pseudomyxoma peritonei patient after surgical treatment and hyperthermic intraperitoneal chemotherapy: A case report. World J Clin Cases 2019; In press |
|
Received |
|
2019-07-20 13:40 |
|
Peer-Review Started |
|
2019-07-23 03:12 |
|
To Make the First Decision |
|
2019-09-16 03:55 |
|
Return for Revision |
|
2019-09-17 02:49 |
|
Revised |
|
2019-09-17 15:29 |
|
Second Decision |
|
2019-09-25 08:44 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2019-10-05 07:02 |
|
Articles in Press |
|
2019-10-05 07:02 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2019-10-07 03:29 |
|
Typeset the Manuscript |
|
2019-11-04 00:52 |
ISSN |
2307-8960 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345